Yahoo Finance

Hepta Unveils First Multi-Omic Atlas of MASH, Linking Liver Pathway Biology to cfDNA Methylation in Blood

FOSTER CITY, Calif., November 10, 2025--(BUSINESS WIRE)--Hepta, a biotechnology company using transformer-based AI to decode the cell-free DNA (cfDNA) epigenome and detect organ-specific signals of ...
ascopubs.org

A novel artificial intelligence-enhanced electrochemical method for rapid methylation detection in cfDNA: Advancing multi-cancer early diagnosis.

Stronger together: Implementing patient-reported symptom tool in routine cancer care in diverse Asia—A multi-national pilot feasibility study (PROMiSE-Pilot). This is an ASCO Meeting Abstract from the ...
ascopubs.org

Tissue of origin detection for cancer tumor using low-depth cfDNA samples through combination of tumor-specific methylation atlas and genome-wide methylation density in graph ...

Validation of a chemotherapy toxicity prediction model in older adults with cancer in Taiwan. This is an ASCO Meeting Abstract from the ASCO Breakthrough: A Global Summit for Oncology Innovators. This ...
News Medical

Cancer-related DNA changes may appear in blood years before diagnosis

A recent study in the journal Cell Genomics suggests that genome-wide cell-free deoxyribonucleic acid (cfDNA) methylation patterns may help stratify cancer risk years before diagnosis, with stronger ...
Medscape

Biopsy Based on cfDNA Could Reveal Increased Risk for Cancer

Analysis of cell-free DNA (cfDNA) in plasma samples could help the risk stratification of patients for cancer years before diagnosis, according to new research. In the future, this technology could be ...